Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

The future of legal pot

Roger Collier
CMAJ June 05, 2017 189 (22) E788-E789; DOI: https://doi.org/10.1503/cmaj.1095424
Roger Collier
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Part I: The public health perspective

It remains uncertain exactly how the recreational marijuana market will operate in Canada, though the federal government provided a glimpse in its proposed bill to legalize cannabis.

Physicians and medical researchers wonder how legalization, slated to become law in July 2018, will affect public health. Marijuana producers want to know, among other things, how advertising and branding will be regulated. Marijuana activists, who have long advocated for legalization, are concerned about restrictions in the proposed legislation.

CMAJ asked various stakeholders about their concerns over the proposed federal legislation. The first part of this two-part article explores the medical community’s perspective. Part two will examine the concerns of marijuana producers and advocates.

A public-health focus

Physicians and researchers are advocating for a recreational market that operates through a public-health lens. Some are concerned that the proposed legislation may be more focused on building a lucrative commercial sector than protecting the health of Canadians, young people in particular.

“We are troubled by several aspects of the new legislation,” Michael Devillaer and James MacKillop of the Peter Boris Centre for Addictions Research said to CMAJ in a joint statement. The centre recently published the report Cannabis Law Reform in Canada: Pretense & Perils.

By setting the minimum age to purchase marijuana legally at 18 instead of higher, the government appears to be overlooking credible evidence that cannabis use can have negative effects on young people’s neurocognitive development, said the researchers.

Also, the government did not ban advertising, as recommended by many public health organizations. This will allow cannabis producers to target specific market segments, such as women, former users and curiosity-seekers. The researchers are also concerned about how legalization will affect the medical cannabis sector, which they say should operate within the health care system.

“In setting the legal age of access at 18 and not banning advertising, the Cannabis Act appears too industry-friendly, at the potential expense of public health,” according to Devillaer and MacKillop. “In sum, the legalization of cannabis presents a many-headed hydra from a public health and legal perspective. Although the Task Force [on Cannabis Legalization and Regulation] and Cannabis Act address many aspects, major gaps remain present.”

The Canadian Medical Association (CMA) also adopted a public health stance, on the marijuana bill, stating in a media release that the government “must focus first and foremost on protecting Canadians and reducing any potential harms to health.” The CMA highlighted the particular risk of cannabis use on the brain development of youth, and recommended a broad public-health-policy approach that would include efforts to prevent abuse and dependence, enhance research and monitoring, and provide treatment and harm-reduction services.

Figure

Some physicians and health researchers think the minimum age to purchase marijuana should be higher than 18 years old.

Image courtesy of myshkovsky/iStock

Though the proposed bill is federal, it will be left to the provinces to design their distribution systems for retail marijuana, and that is no trivial task, according to Dr. Benedikt Fischer, a senior scientist with the Centre for Addiction and Mental Health. In an opinion piece in The Globe and Mail, he wrote that “getting the design of retail models right will be crucial for whether legalization will work for or against the paramount goal of furthering public health.” A public-health-focused distribution system would be free of advertising, promote low-risk use and have pricing that brings users to the legal market but keeps demand low, according to Fischer.

In Ontario, the provincially run Liquor Control Board of Ontario (LCBO) should be at the core of marijuana distribution, recommended Fischer. It has the infrastructure, experience handling a psychoactive substance and the backing of Ontario Premier Kathleen Wynne. “Hence, it is a ready-to-go system well designed for the safe and sensible distribution of cannabis products,” he wrote.

Private dispensaries and corner stores are also distribution options, though they would have to be held to certain standards, such as allowing purchase only within a limited number of hours a day. In addition, the marijuana products should be stored behind the counter and handled only by trained staff. The Retail Council of Canada is consulting with retailors and governments on this issue.

The storefront option, however, is not a popular one with some health advocates. The ease of availability could encourage overuse of marijuana. Also, it would be harder for regulators to ensure that hundreds of small businesses and private dispensaries, as compared to a single government-run entity like the LCBO, are adhering to rules governing advertising, marketing, branding, serving sizes, potency and packaging.

There have also been concerns raised about the safety and sources of marijuana sold in storefront dispensaries, which are and will remain illegal until the proposed legislation passes. When asked about this form of distribution last year, Michel Picard, a Member of Parliament and member of the Standing Committee on Public Safety and National Security, said, “These storefronts sell untested products that may be unsafe and of particular risk to kids and they are supplied by illegal growers.”

Another option for recreational distribution is via online orders. Or the recreational market could follow the lead of the medical stream and provide access by mail order. These channels would need to be safe and secure, however, and would have to be implemented to ensure youth can’t gain access.

The federal government has already stated, in fact, that online sales will be restricted. You will need more than a few cannabis plants and an Internet connection to enter this part of the commercial market. The proposed legislation states that only “federally licensed producers” will be permitted to sell online, and those producers must be able to provide “secure home delivery through the mail or by courier.”

The Canadian Association for Pharmacy Distribution Management, which supplies medicines for drugstores and hospitals, has suggested that its existing distribution system would be superior to mail order for moving cannabis. The association’s CEO, David Johnston, has stated that it already has the infrastructure to handle recalls in any part of the country, even rural areas.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (22)
CMAJ
Vol. 189, Issue 22
5 Jun 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The future of legal pot
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The future of legal pot
Roger Collier
CMAJ Jun 2017, 189 (22) E788-E789; DOI: 10.1503/cmaj.1095424

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The future of legal pot
Roger Collier
CMAJ Jun 2017, 189 (22) E788-E789; DOI: 10.1503/cmaj.1095424
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Part I: The public health perspective
    • A public-health focus
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What to know about Omicron XBB.1.5
  • Could a flu shot push help curb pediatric hospitalizations?
  • Stalemate: What’s holding up a new health accord?
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire